ADVERTISEMENT
DEA Again Promises to Improve Access to Marijuana for Research
DEA Again Promises to Improve Access to Marijuana for Research
After years of stalling, the agency says it plans to provide notice on pending applications from growers—but only after it establishes new regulations for suppliers.
DEA Again Promises to Improve Access to Marijuana for Research
DEA Again Promises to Improve Access to Marijuana for Research

After years of stalling, the agency says it plans to provide notice on pending applications from growers—but only after it establishes new regulations for suppliers.

After years of stalling, the agency says it plans to provide notice on pending applications from growers—but only after it establishes new regulations for suppliers.

public health, regulation, genetics & genomics

Gene-Edited Soybean Oil Makes Restaurant Debut
Carolyn Wilke | Mar 13, 2019 | 2 min read
A Minnesota-based company reports the sale of a soybean oil engineered to have greater stability and no trans-fat.
bio business
Companies Use CRISPR to Improve Crops
Ashley P. Taylor | Feb 1, 2019 | 9 min read
The agritech industry is editing plant genomes to feed a growing population, expand the produce aisle, and make tastier, more convenient food products.
USDA Approves Edible Cotton
Jef Akst | Oct 29, 2018 | 2 min read
While farmers have the green light to grow the genetically engineered plant, FDA approval is still needed before the seeds are sold as food.
Opinion: No, FDA Didn’t Really Approve 23andMe’s BRCA Test
Cecile Janssens | Mar 19, 2018 | 3 min read
Rather, the breast cancer mutation screen was classified as a type of medical device with obligations for the company to reduce risks to customers.
EU Advisor Recommends Regulatory Exemption for Gene Editing
Catherine Offord | Jan 18, 2018 | 2 min read
Crops produced using mutagenic technologies such as CRISPR should generally be exempt from regulatory laws governing GMOs, according to the published opinion.
Following FDA OK, 23andMe to Expand Health Prediction
Kerry Grens | Oct 21, 2015 | 2 min read
The personal genomics firm is ramping up its suite of disease-related genetic tests.
FDA OKs 23andMe Test
Kerry Grens | Feb 20, 2015 | 1 min read
The US Food and Drug Administration will allow the personal genomics company to resume a disease-risk analysis.
The Year in Pathogens
Molly Sharlach | Dec 28, 2014 | 4 min read
Ebola, MERS, and enterovirus D68; polio eradication efforts; new regulations on potentially dangerous research
23andMe Steps Back
Abby Olena, PhD | Dec 6, 2013 | 2 min read
The company announces that it will stop offering health interpretations of personal genetic data.
More Thoughts on Humanized Animals
Jef Akst | Sep 27, 2011 | 1 min read
A German ethics council weighs in on the discussion about the use of human-animal chimeras in research.
ADVERTISEMENT